A transendocytosis perspective on the CD28/CTLA-4 pathway

Advances in Immunology

Volumn 124, Issue , 2014, Pages 95-136

  Soskic, Blagoje ^a   Qureshi, Omar S ^b   Hou, Tiezheng ^c   Sansom, David M ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UCB   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD28; CD80; CD86; Costimulation; CTLA 4; Tolerance; Transendocytosis; Treg

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; CELL METABOLISM; CELLULAR IMMUNITY; CLONAL ANERGY; COMPLEX FORMATION; ENDOCYTOSIS; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LIGAND BINDING; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMUS; TRANSENDOCYTOSIS; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; AUTOIMMUNITY; CTLA-4 ANTIGEN; ENDOCYTOSIS; HUMANS; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84906748681     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800147-9.00004-2     Document Type: Chapter

References (223)

1. Amsen D., Kruisbeek A.M. CD28-B7 interactions function to co-stimulate clonal deletion of double-positive thymocytes. International Immunology 1996, 8(12):1927-1936.
2. Araki M., Chung D., Liu S., Rainbow D.B., Chamberlain G., Garner V., et al. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. Journal of Immunology 2009, 183(8):5146-5157.
3. Arens R., Loewendorf A., Redeker A., Sierro S., Boon L., Klenerman P., et al. Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations. Journal of Immunology 2011, 186(7):3874-3881.
4. Azuma M., Ito D., Yagita H., Okumura K., Phillips J., Lanier L., et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993, 366:76-79.
5. Azuma M., Yssel H., Phillips J., Spits H., Lanier L. Functional expression of B7/BB1 on activated T lymphocytes. The Journal of Experimental Medicine 1993, 177:845-850.
6. Baban B., Chandler P., McCool D., Marshall B., Munn D.H., Mellor A.L. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. Journal of Reproductive Immunology 2004, 61(2):67-77.
7. Bachmann M.F., Gallimore A., Jones E., Ecabert B., Acha-Orbea H., Kopf M. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: A paradigm reconsidered. European Journal of Immunology 2001, 31(2):450-458.
8. Bachmann M.F., Kohler G., Ecabert B., Mak T.W., Kopf M. Cutting edge: Lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. Journal of Immunology 1999, 163(3):1128-1131.
9. Bachmann M.F., Waterhouse P., Speiser D.E., McKall-Faienza K., Mak T.W., Ohashi P.S. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. Journal of Immunology 1998, 160(1):95-100.
10. Bhatia S., Sun K., Almo S.C., Nathenson S.G., Hodes R.J. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation. Journal of Immunology 2010, 184(4):1821-1828.
11. Boesteanu A.C., Katsikis P.D. Memory T cells need CD28 costimulation to remember. Seminars in Immunology 2009, 21(2):69-77.
12. Boomer J.S., Green J.M. An enigmatic tail of CD28 signaling. Cold Spring Harbor Perspectives in Biology 2010, 2(8):a002436.
13. Borowski A.B., Boesteanu A.C., Mueller Y.M., Carafides C., Topham D.J., Altman J.D., et al. Memory CD8+ T cells require CD28 costimulation. Journal of Immunology 2007, 179(10):6494-6503.
14. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997, 6:303-313.
15. Boulougouris G., McLeod J.D., Patel Y.I., Ellwood C.N., Walker L.S., Sansom D.M. IL-2-independent activation and proliferation in human T cells induced by CD28. Journal of Immunology 1999, 163(4):1809-1816.
16. Bour-Jordan H., Esensten J.H., Martinez-Llordella M., Penaranda C., Stumpf M., Bluestone J.A. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunological Reviews 2011, 241(1):180-205.
17. Boussiotis V.A., Freeman G.J., Gribben J.G., Nadler L.M. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunological Reviews 1996, 153:5-26.
18. Broux B., Markovic-Plese S., Stinissen P., Hellings N. Pathogenic features of CD4+CD28- T cells in immune disorders. Trends in Molecular Medicine 2012, 18(8):446-453.
19. Brown D.R., Green J.M., Moskowitz N.H., Davis M., Thompson C.B., Reiner S.L. Limited role of CD28-mediated signals in T-helper subset differentiation. The Journal of Experimental Medicine 1996, 184:803-810.
20. Buelens C., Verhasselt V., De Groote D., Thielemans K., Goldman M., Willems F. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. European Journal of Immunology 1997, 27(8):1848-1852.
21. Buhlmann J.E., Elkin S.K., Sharpe A.H. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. Journal of Immunology 2003, 170(11):5421-5428.
22. Butte M.J., Keir M.E., Phamduy T.B., Sharpe A.H., Freeman G.J. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007, 27(1):111-122.
23. Carman J.A., Davis P.M., Yang W.P., Zhu J., Chang H., He A., et al. Abatacept does not induce direct gene expression changes in antigen-presenting cells. Journal of Clinical Immunology 2009, 29(4):479-489.
24. Caux C., Vanbervliet B., Massacrier C., Azuma M., Okumura K., Lanier L.L., et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. The Journal of Experimental Medicine 1994, 180(5):1841-1847.
25. Chattopadhyay G., Shevach E.M. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. Journal of Immunology 2013, 191(12):5875-5884.
26. Chuang E., Alegre M.L., Duckett C.S., Noel P.J., Vander Heiden M.G., Thompson C.B. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. Journal of Immunology 1997, 159(1):144-151.
27. Cobbold S.P. The mTOR pathway and integrating immune regulation. Immunology 2013, 140(4):391-398.
28. Cobbold S.P., Waldmann H. Regulatory cells and transplantation tolerance. Cold Spring Harbor Perspectives in Medicine 2013, 3(6). http://dx.doi.org/0.1101/cshperspect.a015545.
29. Collins A., Brodie D., Gilbert R., Iaboni A., Manso-Sancho R., Walse B., et al. The interaction properties of costimulatory molecules revisited. Immunity 2002, 17(2):201-210.
30. Collins M., Ling V., Carreno B.M. The B7 family of immune-regulatory ligands. Genome Biology 2005, 6(6):223.
31. Corcoran K., Jabbour M., Bhagwandin C., Deymier M.J., Theisen D.L., Lybarger L. Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). Journal of Biological Chemistry 2011, 286(43):37168-37180.
32. Corse E., Allison J.P. Cutting edge: CTLA-4 on effector T cells inhibits in trans. Journal of Immunology 2012, 189(3):1123-1127.
33. Cowan J.E., Parnell S.M., Nakamura K., Caamano J.H., Lane P.J., Jenkinson E.J., et al. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development. The Journal of Experimental Medicine 2013, 210(4):675-681.
34. Croft M., So T., Duan W., Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunological Reviews 2009, 229(1):173-191.
35. Crooks M.E., Littman D.R., Carter R.H., Fearon D.T., Weiss A., Stein P.H. CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Molecular and Cellular Biology 1995, 15(12):6820-6828.
36. Daubeuf S., Aucher A., Bordier C., Salles A., Serre L., Gaibelet G., et al. Preferential transfer of certain plasma membrane proteins onto T and B cells by trogocytosis. PLoS One 2010, 5(1):e8716.
37. Davis D.M. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nature Reviews. Immunology 2007, 7(3):238-243.
38. Davis P.M., Nadler S.G., Stetsko D.K., Suchard S.J. Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction. Clinical Immunology 2008, 126(1):38-47.
39. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 2011, 12(4):295-303.
40. Dodson L.F., Boomer J.S., Deppong C.M., Shah D.D., Sim J., Bricker T.L., et al. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. Molecular and Cellular Biology 2009, 29(13):3710-3721.
41. Dooms H., Abbas A.K. Control of CD4+ T-cell memory by cytokines and costimulators. Immunological Reviews 2006, 211:23-38.
42. Doty R.T., Clark E.A. Two regions in the CD80 cytoplasmic tail regulate CD80 redistribution and T cell costimulation. Journal of Immunology 1998, 161(6):2700-2707.
43. Eberlein J., Davenport B., Nguyen T.T., Victorino F., Sparwasser T., Homann D. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity. Journal of Virology 2012, 86(4):1955-1970.
44. Edmead C.E., Patel Y.I., Wilson A., Boulougouris G., Hall N.D., Ward S.G., et al. Induction of NFkB and AP-1by CD28 signalling involves both PI-3 kinase and acidic sphingomyelinase signals. Journal of Immunology 1996, 57:3290-3297.
45. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002, 16(1):23-35.
46. Etemire E., Krull M., Hasenberg M., Reichardt P., Gunzer M. Transiently reduced PI3K/Akt activity drives the development of regulatory function in antigen-stimulated Naive T-cells. PLoS One 2013, 8(7):e68378.
47. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunology 2003, 4(12):1206-1212.
48. Fehervari Z., Yamaguchi T., Sakaguchi S. The dichotomous role of IL-2: Tolerance versus immunity. Trends in Immunology 2006, 27(3):109-111.
49. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 2003, 4(4):330-336.
50. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002, 16(6):769-777.
51. Freedman A.S., Freeman G.J., Rhynhart K., Nadler L.M. Selective induction of B7/BB1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway. Cellular Immunology 1991, 137:429-440.
52. Freeman G.J., Gray G.S., Gimmi C.D., Lombard D.B., Zhou L., White M., et al. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. The Journal of Experimental Medicine 1991, 174:625-631.
53. Freeman G.J., Gribben J.G., Boussiotis V.A., Ng J.W., Restivo V.A., Lombard L.A., et al. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993, 262:909-912.
54. Friedline R.H., Brown D.S., Nguyen H., Kornfeld H., Lee J., Zhang Y., et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. The Journal of Experimental Medicine 2009, 206(2):421-434.
55. Gabrysova L., Christensen J.R., Wu X., Kissenpfennig A., Malissen B., O'Garra A. Integrated T-cell receptor and costimulatory signals determine TGF-beta-dependent differentiation and maintenance of Foxp3+ regulatory T cells. European Journal of Immunology 2011, 41(5):1242-1248.
56. Garcon F., Patton D.T., Emery J.L., Hirsch E., Rottapel R., Sasaki T., et al. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 2008, 111(3):1464-1471.
57. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. Journal of Immunology 1999, 162(8):4567-4575.
58. Girard T., El-Far M., Gaucher D., Acuto O., Beaule G., Michel F., et al. A conserved polylysine motif in CD86 cytoplasmic tail is necessary for cytoskeletal association and effective co-stimulation. Biochemical and Biophysical Research Communications 2012, 423(2):301-307.
59. Gogishvilli T., Luhder F., Goebbels S., Beer-Hammer S., Pfeffer K., Hunig T. Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion. European Journal of Immunology 2013, 43:188-193.
60. Grant B.D., Donaldson J.G. Pathways and mechanisms of endocytic recycling. Nature Reviews. Molecular Cell Biology 2009, 10(9):597-608.
61. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunology 2002, 3(11):1097-1101.
62. Guo F., Iclozan C., Suh W.K., Anasetti C., Yu X.Z. CD28 controls differentiation of regulatory T cells from naive CD4 T cells. Journal of Immunology 2008, 181(4):2285-2291.
63. Harper K., Balzano C., Rouvier E., Mattei M., Luciani M., Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure and chromosomal location. Journal of Immunology 1991, 147:1037-1044.
64. Hathcock K.S., Laszlo G., Dickler H.B., Bradshaw J., Linsley P., Hodes R.J. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993, 262:905-907.
65. Heissmeyer V., Rao A. E3 ligases in T cell anergy-turning immune responses into tolerance. Science's STKE 2004, 2004(241):pe29.
66. Homann D., Dummer W., Wolfe T., Rodrigo E., Theofilopoulos A.N., Oldstone M.B., et al. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. Journal of Virology 2006, 80(1):270-280.
67. Hunig T. The storm has cleared: Lessons from the CD28 superagonist TGN1412 trial. Nature Reviews. Immunology 2012, 12(5):317-318.
68. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999, 397(6716):263-266.
69. Huynh A., Zhang R., Turka L.A. Signals and pathways controlling regulatory T cells. Immunological Reviews 2014, 258(1):117-131.
70. Iida T., Ohno H., Nakaseko C., Sakuma M., Takeda-Ezaki M., Arase H., et al. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells. Journal of Immunology 2000, 165(9):5062-5068.
71. Ikemizu S., Gilbert R.J., Fennelly J.A., Collins A.V., Harlos K., Jones E.Y., et al. Structure and dimerization of a soluble form of B7-1. Immunity 2000, 12(1):51-60.
72. Inaba K., Inaba M., Witmer-Pack M., Hatchcock K., Hodes R., Steinman R.M. Expression of B7 costimulator molecules on mouse dendritic cells. Advances in Experimental Medicine & Biology 1995, 378:65-70.
73. Inaba K., Witmer-Pack M., Inaba M., Hathcock K.S., Sakuta H., Azuma M., et al. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. The Journal of Experimental Medicine 1994, 180(5):1849-1860.
74. Irla M., Guerri L., Guenot J., Serge A., Lantz O., Liston A., et al. Antigen recognition by autoreactive CD4(+) thymocytes drives homeostasis of the thymic medulla. PLoS One 2012, 7(12):e52591.
75. Ise W., Kohyama M., Nutsch K.M., Lee H.M., Suri A., Unanue E.R., et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nature Immunology 2010, 11(2):129-135.
76. Jain N., Miu B., Jiang J.K., McKinstry K.K., Prince A., Swain S.L., et al. CD28 and ITK signals regulate autoreactive T cell trafficking. Nature Medicine 2013, 19(12):1632-1637.
77. Janeway C.A. How the immune system works to protect the host from infection: A personal view [Review]. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(13):7461-7468.
78. Kastenmuller W., Gasteiger G., Subramanian N., Sparwasser T., Busch D.H., Belkaid Y., et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. Journal of Immunology 2011, 187(6):3186-3197.
79. Kaur S., Qureshi O.S., Sansom D.M. Comparison of the intracellular trafficking itinerary of ctla-4 orthologues. PLoS One 2013, 8(4):e60903.
80. Keir M.E., Sharpe A.H. The B7/CD28 costimulatory family in autoimmunity. Immunological Reviews 2005, 204:128-143.
81. Khattri R., Auger J.A., Griffin M.D., Sharpe A.H., Bluestone J.A. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 response. Journal of Immunology 1999, 162:5784-5791.
82. Kim J.M., Rasmussen J.P., Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunology 2007, 8(2):191-197.
83. Kim H.H., Tharayil M., Rudd C.E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. Journal of Biological Chemistry 1998, 273(1):296-301.
84. Kong K.F., Yokosuka T., Canonigo-Balancio A.J., Isakov N., Saito T., Altman A. A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28. Nature Immunology 2011, 12(11):1105-1112.
85. Koorella C., Nair J.R., Murray M.E., Carlson L.M., Watkins S.K., Lee K.P. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by notch1 in IL-6 and indoleamine 2,3 dioxygenase production by dendritic cells. Journal of Biological Chemistry 2014, 289(11):7747-7762.
86. Krummel M.F., Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. The Journal of Experimental Medicine 1996, 183:2533-2540.
87. Kusakari S., Ohnishi H., Jin F.J., Kaneko Y., Murata T., Murata Y., et al. Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47-SHPS-1 system. Journal of Cell Science 2008, 121(Pt. 8):1213-1223.
88. Lanier L., O'Fallon S., Somoza C., Phillips J.H., Linsley P.S., Okumura K., et al. CD80(B7) and CD86(B70) provide similar costimulatory signals for T cell proliferation, cytokine production and generation of CTL. Journal of Immunology 1995, 154:97-105.
89. Larsen C.P., Knechtle S.J., Adams A., Pearson T., Kirk A.D. A new look at blockade of T-cell costimulation: A therapeutic strategy for long-term maintenance immunosuppression. American Journal of Transplantation 2006, 6(5 Pt 1):876-883.
90. Larsen C.P., Ritchie S.C., Hendrix R., Linsley P.S., Hathcock K.S., Hodes R.J., et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. Journal of Immunology 1994, 152:5208-5219.
91. Lee K.M., Chuang E., Griffin M., Khattri R., Hong D.K., Zhang W., et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998, 282(5397):2263-2266.
92. Lenschow D.J., Herold K.C., Rhee L., Patel B., Koons A., Qin H.Y., et al. CD28/B7 regulation of Th-1 and Th-2 subsets in the development of autoimmune diabetes. Immunity 1996, 5:285-293.
93. Lenschow D., Zeng Y., Thistlethwaite J., Monty A., Brady W., Gibson N., et al. Longterm survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992, 257:780-789.
94. Liang Y., Cucchetti M., Roncagalli R., Yokosuka T., Malzac A., Bertosio E., et al. The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells. Nature Immunology 2013, 14(8):858-866.
95. Liao X.C., Fournier S., Killeen N., Weiss A., Allison J.P., Littman D.R. Itk negatively regulates induction of T cell proliferation by CD28 costimulation. The Journal of Experimental Medicine 1997, 186(2):221-228.
96. Lin A.E., Mak T.W. The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells. Current Opinion in Immunology 2007, 19(6):665-673.
97. Linsley P.S., Bradshaw J., Greene J., Peach R., Bennett K.L., Mittler R.S. Intracellular trafficking of CTLA-4 and focal localisation towards sites of TCR engagement. Immunity 1996, 4:535-543.
98. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. The Journal of Experimental Medicine 1991, 173:721-730.
99. Linsley P., Ledbetter J. The role of the CD28 receptor during T cell responses to antigen. Annual Review of Immunology 1993, 11:191-212.
100. Linterman M.A., Rigby R.J., Wong R., Silva D., Withers D., Anderson G., et al. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS. Immunity 2009, 30(2):228-241.
101. Liu S.M., Sutherland A.P., Zhang Z., Rainbow D.B., Quintana F.J., Paterson A.M., et al. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity. Journal of Immunology 2012, 188(1):155-162.
102. Lohr J., Knoechel B., Jiang S., Sharpe A.H., Abbas A.K. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nature Immunology 2003, 4(7):664-669.
103. London C.A., Lodge M.P., Abbas A.K. Functional responses and costimulator dependence of memory CD4+ T cells. Journal of Immunology 2000, 164(1):265-272.
104. Ma J., Ding Y., Fang X., Wang R., Sun Z. Protein kinase C-theta inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway. Journal of Immunology 2012, 188(11):5337-5347.
105. Madshus I.H., Stang E. Internalization and intracellular sorting of the EGF receptor: A model for understanding the mechanisms of receptor trafficking. Journal of Cell Science 2009, 122(Pt 19):3433-3439.
106. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nature Reviews. Immunology 2004, 4(9):665-674.
107. Mandelbrot D.A., McAdam A.J., Sharpe A.H. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). The Journal of Experimental Medicine 1999, 189:435-440.
108. Manzotti C.N., Liu M.K.P., Burke F., Dussably L., Zheng Y., Sansom D.M. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. European Journal of Immunology 2006, 36:1413-1422.
109. Marengere L.E., Okkenhaug K., Clavreul A., Couez D., Gibson S., Mills G.B., et al. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. Journal of Immunology 1997, 159(7):3220-3229.
110. Marston D.J., Dickinson S., Nobes C.D. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nature Cell Biology 2003, 5(10):879-888.
111. Masteller E.L., Chuang E., Mullen A.C., Reiner S.L., Thompson C.B. Structural analysis of CTLA-4 function in vivo. Journal of Immunology 2000, 164(10):5319-5327.
112. Matzinger P. The danger model: A renewed sense of self. Science 2002, 296(5566):301-305.
113. Mayer E., Holzl M., Ahmadi S., Dillinger B., Pilat N., Fuchs D., et al. CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk. International Immunopharmacology 2013, 15(3):638-645.
114. Mead K.I., Zheng Y., Manzotti C.N., Perry L.C., Liu M.K., Burke F., et al. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells. Journal of Immunology 2005, 174(8):4803-4811.
115. Mehlhop-Williams E.R., Bevan M.J. Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation. The Journal of Experimental Medicine 2014, 211(2):345-356.
116. Mellor A.L., Munn D.H. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nature Reviews. Immunology 2004, 4(10):762-774.
117. Metz R., Smith C., Duhadaway J.B., Chandler P., Baban B., Merlo L.M., et al. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. International Immunology 2014, 26(7):357-367.
118. Metzger T.C., Anderson M.S. Control of central and peripheral tolerance by Aire. Immunological Reviews 2011, 241(1):89-103.
119. Molinero L.L., Miller M.L., Evaristo C., Alegre M.L. High TCR stimuli prevent induced regulatory T cell differentiation in a NF-kappaB-dependent manner. Journal of Immunology 2011, 186(8):4609-4617.
120. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor [Review]. Annual Review of Immunology 2001, 19:683-765.
121. Munn D.H., Mellor A.L. Indoleamine 2,3 dioxygenase and metabolic control of immune responses [Review]. Trends in Immunology 2013, 34(3):137-143.
122. Munn D.H., Sharma M.D., Mellor A.L. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. Journal of Immunology 2004, 172(7):4100-4110.
123. Ndlovu H., Darby M., Froelich M., Horsnell W., Luhder F., Hunig T., et al. Inducible deletion of CD28 prior to secondary Nippostrongylus brasiliensis infection impairs worm expulsion and recall of protective memory CD4(+) T cell responses. PLoS Pathogens 2014, 10(2):e1003906.
124. Noel P.J., Alegre M.L., Reiner S.L., Thompson C.B. Impaired negative selection in CD28-deficient mice. Cellular Immunology 1998, 187(2):131-138.
125. Oderup C., Cederbom L., Makowska A., Cilio C.M., Ivars F. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 2006, 118(2):240-249.
126. Ogawa S., Watanabe M., Sakurai Y., Inutake Y., Watanabe S., Tai X., et al. CD28 signaling in primary CD4(+) T cells: Identification of both tyrosine phosphorylation-dependent and phosphorylation-independent pathways. International Immunology 2013, 25(12):671-681.
127. Okkenhaug K., Rottapel R. Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. Journal of Biological Chemistry 1998, 273(33):21194-21202.
128. Okkenhaug K., Wu L., Garza K.M., La Rose J., Khoo W., Odermatt B., et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nature Immunology 2001, 2(4):325-332.
129. Onishi Y., Fehervari Z., Yamaguchi T., Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(29):10113-10118.
130. Oosterwegel M.A., Mandelbrot D.A., Boyd S.D., Lorsbach R.B., Jarrett D.Y., Abbas A.K., et al. The role of CTLA-4 in regulating Th2 differentiation. Journal of Immunology 1999, 163(5):2634-2639.
131. Pagan A.J., Pepper M., Chu H.H., Green J.M., Jenkins M.K. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. Journal of Immunology 2012, 189(6):2909-2917.
132. Pages F., Ragueneau M., Rottapel R., Truneh A., Nunes J., Imbert J., et al. Binding of phosphatidylinostol-3-OH kinase to CD28 is required for T cell signalling. Nature 1994, 369:327-329.
133. Palmer E., Naeher D. Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nature Reviews. Immunology 2009, 9(3):207-213.
134. Pentcheva-Hoang T., Egen J.G., Wojnoonski K., Allison J.P. B7-1 and b7-2 selectively recruit ctla-4 and CD28 to the immunological synapse. Immunity 2004, 21(3):401-413.
135. Pilat N., Sayegh M.H., Wekerle T. Costimulatory pathways in transplantation. Seminars in Immunology 2011, 23(4):293-303.
136. Powell J.D., Pollizzi K.N., Heikamp E.B., Horton M.R. Regulation of immune responses by mTOR Review]. Annual Review of Immunology 2012, 30:39-68.
137. Pree I., Bigenzahn S., Fuchs D., Koporc Z., Nierlich P., Winkler C., et al. CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase. Transplantation 2007, 83(5):663-667.
138. Qureshi O., Kaur S., Hou T.Z., Jeffery L.E., Poulter N.S., Briggs Z., et al. Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation. Journal of Biological Chemistry 2012, 287:9429-9440.
139. Qureshi O.S., Zheng Y., Nakamura K., Attridge K., Manzotti C., Schmidt E.M., et al. Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332(6029):600-603.
140. Raab M., Cai Y.C., Bunnell S.C., Heyeck S.D., Berg L.J., Rudd C.E. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: Implications for T-cell costimulation. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(19):8891-8895.
141. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. The Journal of Experimental Medicine 2000, 192(2):295-302.
142. Riella L.V., Liu T., Yang J., Chock S., Shimizu T., Mfarrej B., et al. Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. American Journal of Transplantation 2012, 12(4):846-855.
143. Riha P., Rudd C.E. CD28 co-signaling in the adaptive immune response. Self Nonself 2010, 1(3):231-240.
144. Rossi S.W., Kim M.Y., Leibbrandt A., Parnell S.M., Jenkinson W.E., Glanville S.H., et al. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. The Journal of Experimental Medicine 2007, 204(6):1267-1272.
145. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28(4):546-558.
146. Rubtsov Y.P., Rudensky A.Y. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nature Reviews. Immunology 2007, 7(6):443-453.
147. Rudd C.E. The reverse stop-signal model for CTLA4 function. Nature Reviews. Immunology 2008, 8(2):153-160.
148. Safford M., Collins S., Lutz M.A., Allen A., Huang C.T., Kowalski J., et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nature Immunology 2005, 6(5):472-480.
149. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 2005, 6(4):345-352.
150. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000, 12(4):431-440.
151. Sansom D.M. CD28, CTLA-4 and their ligands: Who does what and to whom?. Immunology 2000, 101:169-177.
152. Sansom D.M., Hall N.D. B7/BB1, the ligand for CD28 is expressed on repeatedly activated human T cells in vitro. European Journal of Immunology 1993, 23:295-298.
153. Sansom D.M., Walker L.S. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunological Reviews 2006, 212:131-148.
154. Sansom D.M., Walker L.S. CD28 costimulation: Walking the immunological tightrope [Comment]. European Journal of Immunology 2013, 43(1):42-45.
155. Santra S., Barouch D.H., Sharpe A.H., Letvin N.L. B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination. European Journal of Immunology 2000, 30(9):2650-2659.
156. Sarris M., Andersen K.G., Randow F., Mayr L., Betz A.G. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008, 28(3):402-413.
157. Schildknecht A., Brauer S., Brenner C., Lahl K., Schild H., Sparwasser T., et al. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(1):199-203.
158. Schmidt E.M., Wang C.J., Ryan G.A., Clough L.E., Qureshi O.S., Goodall M., et al. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. Journal of Immunology 2009, 182(1):274-282.
159. Schneider H., Downey J., Smith A., Zinselmeyer B.H., Rush C., Brewer J.M., et al. Reversal of the TCR stop signal by CTLA-4. Science 2006, 313(5795):1972-1975.
160. Schneider H., Martin M., Agarraberes F.A., Yin L., Rapoport I., Kirchhausen T., et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. Journal of Immunology 1999, 163(4):1868-1879.
161. Schwartz R.H. T cell anergy. Annual Review of Immunology 2003, 21:305-334.
162. Schwartz J.C., Zhang X., Fedorov A.A., Nathenson S.G., Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001, 410(6828):604-608.
163. Schweitzer A.N., Borriello F., Wong R.C.K., Abbas A.K., Sharpe A.H. Role of costimulators in T cell differentiation-Studies using antigen-presenting cells lacking expression of CD80 or CD86. Journal of Immunology 1997, 158:2713-2722.
164. Schweitzer A.N., Sharpe A.H. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. Journal of Immunology 1998, 161(6):2762-2771.
165. Semple K., Nguyen A., Yu Y., Wang H., Anasetti C., Yu X.Z. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood 2011, 117(11):3096-3103.
166. Sewell A.K. Why must T cells be cross-reactive?. Nature Reviews. Immunology 2012, 12(9):669-677.
167. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., et al. Differential T cell costimulatory requirements in CD28 deficient mice. Science 1993, 261:609-612.
168. Shiratori T., Miyatake S., Ohno H., Nakaseko C., Isono K., Bonifacino J.S., et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 1997, 6:583-589.
169. Singh N., Chandler P.R., Seki Y., Baban B., Takezaki M., Kahler D.J., et al. Role of CD28 in fatal autoimmune disorder in scurfy mice. Blood 2007, 110(4):1199-1206.
170. Smeets R.L., Fleuren W.W., He X., Vink P.M., Wijnands F., Gorecka M., et al. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunology 2012, 13:12.
171. Stumpf M., Zhou X., Bluestone J.A. The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes. Journal of Immunology 2013, 190(3):961-969.
172. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994, 77:727-736.
173. Su L.F., Kidd B.A., Han A., Kotzin J.J., Davis M.M. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013, 38(2):373-383.
174. Sucher R., Fischler K., Oberhuber R., Kronberger I., Margreiter C., Ollinger R., et al. IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. Journal of Immunology 2012, 188(1):37-46.
175. Tabares P., Berr S., Romer P.S., Chuvpilo S., Matskevich A.A., Tyrsin D., et al. Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08. European Journal of Immunology 2013, 44(4):1225-1236.
176. Tai X., Cowan M., Feigenbaum L., Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nature Immunology 2005, 6(2):152-162.
177. Tai X., Van Laethem F., Sharpe A.H., Singer A. Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(34):13756-13761.
178. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. The Journal of Experimental Medicine 2000, 192(2):303-310.
179. Takeda K., Harada Y., Watanabe R., Inutake Y., Ogawa S., Onuki K., et al. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis. International Immunology 2008, 20(12):1507-1515.
180. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunology 2006, 7(1):83-92.
181. Tang Q., Henriksen K.J., Boden E.K., Tooley A.J., Ye J., Subudhi S.K., et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. Journal of Immunology 2003, 171(7):3348-3352.
182. Tao X., Constant S., Jorritsma P., Bottomly K. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. Journal of Immunology 1997, 159(12):5956-5963.
183. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3:541-547.
184. Tivol E.A., Boyd S.D., McKeon S., Borriello F., Nickerson P., Strom T.B., et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. Journal of Immunology 1997, 158(11):5091-5094.
185. Tze L.E., Horikawa K., Domaschenz H., Howard D.R., Roots C.M., Rigby R.J., et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. The Journal of Experimental Medicine 2011, 208(1):149-165.
186. Vacchio M.S., Williams J.A., Hodes R.J. A novel role for CD28 in thymic selection: Elimination of CD28/B7 interactions increases positive selection. European Journal of Immunology 2005, 35(2):418-427.
187. Valk E., Leung R., Kang H., Kaneko K., Rudd C.E., Schneider H. T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. Immunity 2006, 25(5):807-821.
188. Valk E., Rudd C.E., Schneider H. CTLA-4 trafficking and surface expression. Trends in Immunology 2008, 29(6):272-279.
189. Veiga-Fernandes H., Walter U., Bourgeois C., McLean A., Rocha B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nature Immunology 2000, 1(1):47-53.
190. Verhagen J., Genolet R., Britton G.J., Stevenson B.J., Sabatos-Peyton C.A., Dyson J., et al. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(3):E221-E230.
191. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nature Reviews. Immunology 2008, 8(7):523-532.
192. Vijayakrishnan L., Slavik J.M., Illes Z., Greenwald R.J., Rainbow D., Greve B., et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 2004, 20(5):563-575.
193. Walker L.S. Treg and CTLA-4: Two intertwining pathways to immune tolerance. Journal of Autoimmunity 2013, 45:49-57.
194. Walker L.S., Chodos A., Eggena M., Dooms H., Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. The Journal of Experimental Medicine 2003, 198(2):249-258.
195. Walker L.S., Gulbranson-Judge A., Flynn S., Brocker T., Raykundalia C., Goodall M., et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. The Journal of Experimental Medicine 1999, 190(8):1115-1122.
196. Walker L.S., Sansom D.M. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nature Reviews. Immunology 2011, 11(12):852-863.
197. Walunas T.L., Bakker C.Y., Bluestone J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. The Journal of Experimental Medicine 1996, 183:2541-2550.
198. Walunas T.L., Bluestone J.A. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. Journal of Immunology 1998, 160:3855-3860.
199. Wang C.J., Kenefeck R., Wardzinski L., Attridge K., Manzotti C., Schmidt E.M., et al. Cutting edge: Cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells. Journal of Immunology 2012, 189(3):1118-1122.
200. 3 in T cells. European Journal of Immunology 1993, 23:2572-2577.
201. Watanabe M., Nakajima S., Ohnuki K., Ogawa S., Yamashita M., Nakayama T., et al. AP-1 is involved in ICOS gene expression downstream of TCR/CD28 and cytokine receptor signaling. European Journal of Immunology 2012, 42(7):1850-1862.
202. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995, 270:985-988.
203. Wells A.D. New insights into the molecular basis of T cell anergy: Anergy factors, avoidance sensors, and epigenetic imprinting. Journal of Immunology 2009, 182(12):7331-7341.
204. Williams J.A., Zhang J., Jeon H., Nitta T., Ohigashi I., Klug D., et al. Thymic medullary epithelium and thymocyte self-tolerance require cooperation between CD28-CD80/86 and CD40-CD40L costimulatory pathways. Journal of Immunology 2014, 192(2):630-640.
205. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322(5899):271-275.
206. Wing K., Yamaguchi T., Sakaguchi S. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends in Immunology 2011, 32(9):428-433.
207. Withers D.R., Gaspal F.M., Bekiaris V., McConnell F.M., Kim M., Anderson G., et al. OX40 and CD30 signals in CD4(+) T-cell effector and memory function: A distinct role for lymphoid tissue inducer cells in maintaining CD4(+) T-cell memory but not effector function. Immunological Reviews 2011, 244(1):134-148.
208. Xing Y., Hogquist K.A. T-cell tolerance: Central and peripheral. Cold Spring Harbor Perspectives in Biology 2012, 4(6). 10.1101/cshperspect.a006957.
209. Yamaguchi T., Kishi A., Osaki M., Morikawa H., Prieto-Martin P., Wing K., et al. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(23):E2116-E2125.
210. Yao S., Zhu Y., Zhu G., Augustine M., Zheng L., Goode D.J., et al. B7-h2 is a costimulatory ligand for CD28 in human. Immunity 2011, 34(5):729-740.
211. Yeung M.Y., Najafian N., Sayegh M.H. Targeting CD28 to prevent transplant rejection. Expert Opinion on Therapeutic Targets 2014, 18(2):225-242.
212. Yi L.A., Hajialiasgar S., Chuang E. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo. International Immunology 2004, 16(4):539-547.
213. Yokosuka T., Kobayashi W., Sakata-Sogawa K., Takamatsu M., Hashimoto-Tane A., Dustin M.L., et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation. Immunity 2008, 29(4):589-601.
214. Yokosuka T., Kobayashi W., Takamatsu M., Sakata-Sogawa K., Zeng H., Hashimoto-Tane A., et al. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 2010, 33(3):326-339.
215. Yokosuka T., Saito T. Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters [Review]. Immunological Reviews 2009, 229(1):27-40.
216. Yu C., Sonnen A.F., George R., Dessailly B.H., Stagg L.J., Evans E.J., et al. Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering. Journal of Biological Chemistry 2011, 286(8):6685-6696.
217. Zeng H., Yang K., Cloer C., Neale G., Vogel P., Chi H. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 2013, 499(7459):485-490.
218. Zhang R., Huynh A., Whitcher G., Chang J., Maltzman J.S., Turka L.A. An obligate cell-intrinsic function for CD28 in Tregs. Journal of Clinical Investigation 2013, 123(2):580-593.
219. Zhang X., Schwartz J.C., Almo S.C., Nathenson S.G. Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(5):2586-2591.
220. Zheng Y., Delgoffe G.M., Meyer C.F., Chan W., Powell J.D. Anergic T cells are metabolically anergic. Journal of Immunology 2009, 183(10):6095-6101.
221. Zheng Y., Manzotti C.N., Burke F., Dussably L.M., Qureshi O., Walker L.S.K., et al. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. Journal of Immunology 2008, 181:1683-1691.
222. Zheng Y., Manzotti C.N., Liu M., Burke F., Mead K.I., Sansom D.M. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. Journal of Immunology 2004, 172(5):2778-2784.
223. Zheng Y., Zha Y., Driessens G., Locke F., Gajewski T.F. Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo. The Journal of Experimental Medicine 2012, 209(12):2157-2163.